Product Information
QC EYE DROPS MOISTURIZING RLF is a generic product labeled by Chain Drug Marketing Association, priced at $0.1520 per ML under NDC 83324019114. Its NADAC has been published 88 times since Jan 29, 2025.
QC EYE DROPS MOISTURIZING RLF
Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HClStrength
.1; 1; 1; .05 g/100mL; g/100mL; g/100mL; g/100mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324019114
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
6/17/2026
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
8/15/2024
Pharmacological Classes
Price Statistics
The NADAC for QC EYE DROPS MOISTURIZING RLF has been published 88 times since Jan 29, 2025, and over the history we have for it it has declined 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1520 per ML |
|---|---|
| All-time high | $0.1620 (Jul 16, 2025) |
| All-time low | $0.1420 (Feb 18, 2026) |
| 52-week high | $0.1520 |
| 52-week low | $0.1420 |
| Median price | $0.1475 |
| Average price | $0.1505 |
| Largest weekly change | -10.6% (Jul 23, 2025) |
| Weeks tracked | 88 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Plasma Volume Expander class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC EYE DROPS MOISTURIZING RLF?
The current National Average Drug Acquisition Cost (NADAC) for QC EYE DROPS MOISTURIZING RLF, manufactured by Chain Drug Marketing Association, is $0.1520 per ML (NDC 83324019114), effective Sep 30, 2026.
How has the price of QC EYE DROPS MOISTURIZING RLF changed over time?
Over the history we have for it, the NADAC for QC EYE DROPS MOISTURIZING RLF has declined 3.2%. It has been tracked across 88 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for QC EYE DROPS MOISTURIZING RLF?
Since Jan 29, 2025, the NADAC for QC EYE DROPS MOISTURIZING RLF has ranged from a low of $0.1420 (Feb 18, 2026) to a high of $0.1620 (Jul 16, 2025), with a median of $0.1475 per ML.
Are there cheaper alternatives to QC EYE DROPS MOISTURIZING RLF?
No other NADAC-published product currently shares the active ingredient and strength of QC EYE DROPS MOISTURIZING RLF in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QC EYE DROPS MOISTURIZING RLF?
QC EYE DROPS MOISTURIZING RLF (NDC 83324019114) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.